z-logo
open-access-imgOpen Access
The MEK Inhibitor Trametinib Suppresses Major Histocompatibility Antigen-mismatched Rejection Following Pancreatic Islet Transplantation
Author(s) -
Seiichiro Tada,
Takayuki Anazawa,
Takero Shindo,
Kei Yamane,
Kenta Inoguchi,
Nozomu Fujimoto,
Kazuyuki Nagai,
Toshihiko Masui,
Hideaki Okajima,
Kyoichi Takaori,
Shoichiro Sumi,
Shinji Üemoto
Publication year - 2020
Publication title -
transplantation direct
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.648
H-Index - 9
ISSN - 2373-8731
DOI - 10.1097/txd.0000000000001045
Subject(s) - trametinib , islet , medicine , transplantation , major histocompatibility complex , immunology , antigen , pharmacology , endocrinology , diabetes mellitus , mapk/erk pathway , kinase , biology , microbiology and biotechnology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here